DGAP-News: Biohacks GmbH / Key word(s): Product Launch
03.02.2021 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
DGAP-News: Biohacks GmbH / Key word(s): Product Launch
03.02.2021 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
The "Spain Gift Card and Incentive Card Market Intelligence and Future Growth Dynamics (Databook): Spend Analysis by Digital/e-Gift Card, Retail & Corporate Consumers, Top Retailers, Distribution Channel, Occasions, and Demographics - Jan 2021 Update" report has been added to ResearchAndMarkets.com's offering.
Dublin, March 05, 2021 (GLOBE NEWSWIRE) -- The "U.S. Faster Payments Forecast: The Volume Begins to Build" report has been added to ResearchAndMarkets.com's offering. The pace of real-time and faster payments adoption accelerated in the U.S. during 2020 as explored in new research, U.S. Faster Payments Forecast: The Volume Begins to Build. Solutions such as debit push payments, The Clearing House RTP network, Same Day ACH, and Zelle all experienced strong double-digit and even triple-digit growth in certain use cases. Gains were in part due to the unique environment created by the global pandemic which values fast digital payment types, plus the simple fact that financial institutions and fintechs alike continued to integrate and launch new payment options for customers and members. "More financial institutions completed technical integrations with faster and real-time networks, not only driving transactions from their customers and members for these products, but also beginning to drive internal efficiencies leveraging the new payment rails for account transfers, vendor payments, or payments from clients for loans and credit cards. Faster and real-time payments came to the rescue during the global pandemic, providing more convenient P2P transactions and opportunities including same day settlement for smaller retailers who appreciated receiving their merchant settlement more quickly," comments Sarah Grotta, Director, Debit and Alternative Products Advisory Service. Highlights of the report include: A view into the current state of progression for The Clearing House RTP system, Early Warning's Zelle network, the global debit networks' push payments and Same Day ACHA forecast for dollar volumes processed for each of the networksDiscussion of some of the misnomers and myths circulating about faster and real-time paymentsCurrent use cases where faster payments are succeedingWhere the next wave of faster payments growth is likely to emerge Key Topics Covered: Executive Summary Introduction A DefinitionDispelling Some Myths Where the Market is Growing Now on Available Networks FedNow Debit Card Network Push Payments RTPSame Day ACHZelle Conclusion: Three Key Drivers that Will Power the Next Wave of Growth References Related ResearchEndnotes For more information about this report visit https://www.researchandmarkets.com/r/exvv9z CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager email@example.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
The "Improving Cash Cycle Management Is a Key to Corporate Stability" report has been added to ResearchAndMarkets.com's offering.
The "2021 Women's Beauty Supplements Market With Covid-19 Impact: Japan" report has been added to ResearchAndMarkets.com's offering.
A white telephone box in a remote village of Japan has become an unlikely source of comfort for those grieving loved ones.Survivors of the 2011 Fukushima disaster say the unconnected phone line helps them keep in touch with those they have lost.Kazuyoshi Sasaki visits the booth in the town of Otsuchi to speak to his late wife.She was one of nearly 20,000 people in northeastern Japan who were killed by the earthquake and tsunami that struck on March 11, 2011.Dialling her now defunct cell, he breaks down in tears as he explains to her how he searched for her for days after the disaster.He goes onto update her on things that have happened in his life - he's moved out of temporary housing, their son is building him a house, and he's lost a bit of weight.For Sasaki, the phone booth is a source of solace:"This phone booth embraces all of me. It embraces various people like the people affected (from the earthquake and tsunami). It's a place that embraces not only the people who are alive but also those who had passed away. That's how I feel."Sachiko Okawa uses the phone to call her late husband, who she was married to for 44 years.She asks him what he's been doing since he was swept away all those years ago in the Tsunami.She often brings along her two grandsons so they can also talk to their grandfather.The phone now attracts thousands of visitors from all over Japan. It is not only used by tsunami survivors, but also by people who have lost relatives to sickness and suicide. Known as the wind phone, it was built by Itaru Sasaki, who created it after he lost his own cousin to cancer a year before the Fukushima disaster.
At present the government has banned all holidays from the UK before 17 May at the earliest
Dublin, March 05, 2021 (GLOBE NEWSWIRE) -- The "Wearable Injectors Market Size, Share & Trends Analysis Report by Type (On-body, Off-body), by Technology (Spring-based, Motor-driven), by Application (Oncology, Autoimmune Diseases), by End Use, and Segment Forecasts, 2021-2028" report has been added to ResearchAndMarkets.com's offering. The global wearable injectors market size is expected to reach USD 18.3 billion by 2028. It is expected to expand at a CAGR of 17.2% from 2021 to 2028. Wearable injectors are drug administration devices designed to deliver drugs in large volumes subcutaneously. It is gaining popularity owing to its advantages such as reduced pain, ease of administration, and elimination of costly health facility visits.Over the last decade, patient interest in the self-administration of injectable drug therapies has grown. The increasing prevalence of diabetes, chronic pain, and auto-immune diseases, such as rheumatoid arthritis, is increasing the use of wearable injectors. Their demand is increasing for the long-term management of asthma, chronic obstructive pulmonary disease (COPD), high cholesterol, and cancer. This is expected to create a lucrative opportunity for advanced device manufacturers to make wearable devices used to administer larger dose volumes at the comfort of home.The recent COVID-19 pandemic has brought remote care technologies, such as wearable injectors, into the spotlight. Demand for chronic disease products remains largely unaffected by the pandemic. Since wearable injectors serve with the option of delivering medications at home, its demand has also remained stable or rather grown for the short term. Patients suffering from chronic diseases are opting for these devices as it reduces the risk of exposure to COVID-19 by eliminating hospital visits. The pandemic has, however, affected some of the devices in the pipeline, affecting short-term investments. Leading players who continue to invest in innovation push projects forward despite COVID-19 are expected to put their companies in a stronger competitive position post-crisis.Wearable Injectors Market Report Highlights By type, the on-body segment led the market in 2020 owing to its advantage to be worn on the skin.The spring-based technology segment held the largest share of 36.3% in 2020 due to a rise in demand for adhesive patches for the treatment of chronic conditions, such as cancer and diabetes.The home care end-use segment led the market in 2020. This can be attributed to a rise in preference for self-administration, especially during the COVID-19 pandemic.North America dominated the market with a share of 41.5% in 2020 owing to the rising prevalence of chronic diseases. Key Topics Covered: Chapter 1. Methodology and ScopeChapter 2. Executive Summary2.1. Market Outlook2.2. Segment Outlook2.3. Competitive InsightsChapter 3. Wearable Injectors Market Variables, Trends & Scope3.1. Penetration & Growth Prospect Mapping3.2. Industry Value Chain Analysis3.2.1. Reimbursement framework3.3. Market Dynamics3.3.1. Market driver analysis3.3.2. Market restraint analysis3.3.3. Industry challenges3.4. Wearable Injectors Market Analysis Tools3.4.1. Industry Analysis-Porter's3.4.2. PESTEL Analysis3.4.3. Major Deals & Strategic Alliances Analysis3.4.4. Market Entry StrategiesChapter 4. Wearable Injectors Market: Type Estimates & Trend Analysis4.1. Segment Dashboard4.2. Definitions and Scope4.3. Wearable Injectors Market Share, 2020 & 20284.4. Market Size & Forecasts and Trend Analyses, 2016 to 2028 for the following4.4.1. On-body4.4.2. Off-bodyChapter 5. Wearable Injectors Market: Technology Estimates & Trend Analysis5.1. Segment Dashboard5.2. Definitions and Scope5.3. Wearable Injectors Market Share, 2020 & 20285.4. Market Size & Forecasts and Trend Analyses, 2016 to 2028 for the following5.4.1. Spring-based5.4.2. Motor-driven5.4.3. Rotary Pump5.4.4. Expanding Battery5.4.5. OthersChapter 6. Wearable Injectors Market: Application Estimates & Trend Analysis6.1. Segment Dashboard6.2. Definitions and Scope6.3. Wearable Injectors Market Share, 2020 & 20286.4. Market Size & Forecasts and Trend Analyses, 2016 to 2028 for the following6.4.1. Oncology6.4.2. Infectious Diseases6.4.3. Cardiovascular Diseases6.4.4. Autoimmune Diseases6.4.5. OthersChapter 7. Wearable Injectors Market: End-use Estimates & Trend Analysis7.1. Segment Dashboard7.2. Definitions and Scope7.3. Wearable Injectors Market Share, 2020 & 20287.4. Market Size & Forecasts and Trend Analyses, 2016 to 2028 for the following7.4.1. Hospitals7.4.2. Clinics7.4.3. Home Care7.4.4. OthersChapter 8. Wearable Injectors: Regional Estimates & Trend Analysis8.1. Regional Market Dashboard8.2. Regional Market Share Analysis, 2020 & 20288.3. Regional Market Share, 2020Chapter 9. Competitive Landscape9.1. Recent Developments & Impact Analysis, By Key Market Participants9.1.1. Company overview9.1.2. Financial performance9.1.3. Product benchmarking9.1.4. Strategic initiatives Becton, Dickinson and CompanyJohnson & Johnson Services, Inc.F. Hoffmann-La Roche Ltd.Unilife CorporationSteadyMed Therapeutics, Inc.Amgen Inc.Insulet CorporationEnable InjectionsWest Pharmaceutical Services, Inc.CeQur SA For more information about this report visit https://www.researchandmarkets.com/r/b3ts7w CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager firstname.lastname@example.org For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
Nadine Dorries says nurses ‘do their job because they love their job’ amid outrage over ‘pitiful’ increase
Jealous that his ex-girlfriend had brought home her new boyfriend, he threw the man's slippers into the washing machine and slashed him with a chopper.
'All I've wanted is to give mum a hug': four families kept apart by CovidPeople tell how they have been affected by travel rules stopping them from meeting loved onesCoronavirus – latest updatesSee all our coronavirus coverage Laura Myers, who lives in Sweden, and her mother, Debra. Photograph: Laura Myers
The former England international received a barrage of abuse over a tongue-in-cheek post.
“I’m assuming this is satire. So hard to tell with people who suck at this,” responded “Star Trek” actor George Takei.
With over 700 five-star reviews on Amazon, we had high hopes…
This beautiful Grade II-listed home is a stone’s throw away from the city of Bath
Dr. Michael Osterholm delivers a stark warning to states moving to reopen too quickly.
Council tax bills could rise by £100 a month from April after local councils were given powers to increase rates without consultation. Office for Budget Responsibility (OBR) said in a report that local authorities would increase taxes by £1.8 billion next month after the Government allowed them to impose increases of up to 5 per cent. A referendum is usually required if councils propose raising the tax by 2 per cent or more.
France TV Distribution has closed a raft of sales on “Hear Me Out,” a romantic comedy directed by French actor-turned-helmer Pascal Elbé (“Thank You for Calling,” “Turk’s Head”). The film stars Elbé as Antoine, a fifty-year old history professor who discovers that he’s losing his hearing and starts having a recluse life because of his […]
The stadium giants are back with a weirdly prophetic eighth album and a whole lot of eagerness to get on the road. They talk to Laura Barton about growing up, sticking it to the haters and why the people need rock’n’roll
Dublin, March 05, 2021 (GLOBE NEWSWIRE) -- The "Facial Injectable Market Size, Share & Trends Analysis Report by Product (Collagen, Hyaluronic Acid, Botulinum Toxin Type A, Calcium Hydroxylapatite, Polymer Fillers), by Application, by Region, and Segment Forecasts, 2021 - 2028" report has been added to ResearchAndMarkets.com's offering. The global facial injectable market size is expected to reach USD 27.7 billion by 2028. It is expected to expand at a CAGR of 8.8% from 2021 to 2028. The facial injectable is a substance that is used to reduce wrinkles and restore volume and fullness in the face. It is injected beneath the facial skin surface. Some commonly used facial injectables include hyaluronic acid, botulinum toxin type A, and polymer fillers.The growing focus on physical appearance, especially in developing countries, is one of the key factors expected to drive the market. In addition, a shift in consumer preference toward minimally invasive procedures is expected to support market growth. According to the American Society of Plastic Surgeons (ASPS), in 2019, botulinum toxin A and soft tissue fillers were among the top 5 minimally invasive procedures carried out in the U.S. Thus, facial injectable holds high growth prospects in the years to come.The Asia Pacific region is expected to serve as a key revenue-generating center. The region is backed by countries, such as India, where a growing focus on physical appearance is expected to create a lucrative opportunity for the market. Companies such as Allergan are also expanding their presence in the country owing to the rise in the middle-class population, backed by increasing disposable income.With non-urgent and cosmetic surgeries being put on hold in most of the clinics across the world, surgeons are consulting their patients via telemedicine. Some surgeons are expecting an initial rush once the clinic reopens due to backlog cases, however, in the long run, they predict changes in the near future. There will also be an additional impact on revenue. With deep sanitization and PPEs to be worn for even injectable procedures, small businesses are expected to undergo the overhead expense and a decreased revenue, many could even shut down.Facial Injectable Market Report Highlights By product, the botulinum toxin type A segment led the market in 2020 and is projected to dominate throughout the forecast period. It is one of the most popularly used minimally invasive procedures.Based on application, the aesthetics segment is projected to be the fastest-growing segment over the forecast period owing to the rise in the use of facial injectables for aesthetic procedures, such as the treatment of wrinkles on the face.North America dominated the market in 2020 with a share of over 41.0% owing to the easy availability of the products and the presence of a large number of skilled surgeons. Key Topics Covered: Chapter 1. Methodology and ScopeChapter 2. Executive SummaryChapter 3. Facial Injectable Market Variables, Trends & Scope3.1. Penetration & Growth Prospect Mapping3.2. Market Dynamics3.2.1. Market Driver Analysis220.127.116.11. Increasing beauty consciousness among consumers18.104.22.168. Shift in consumer preference toward minimally invasive procedures3.2.2. Market Restraint Analysis3.3. Non-invasive Aesthetic Treatment: Market Analysis Tools3.3.1. Industry Analysis - Porter's3.3.2. PESTEL AnalysisChapter 4. Facial Injectable Market: Segment Analysis, By Product, 2016 - 2028 (USD Million)4.1. Definitions & Scope4.2. Product market share analysis, 2020 & 20284.3. Global Facial Injectable Market, By Product, 2016 - 20284.4. Market Size & Forecasts and Trend Analysis, 2016 - 2028 for the following4.4.1. Collagen4.4.2. Botulinum Toxin Type A4.4.3. Hyaluronic Acid (HA)4.4.4. Calcium Hydroxylapatite (CaHA)4.4.5. Polymer Fillers22.214.171.124. Polymethylmethacrylate beads (PMMA Microspheres)126.96.36.199. Poly-L-Lactic Acid (PLLA)Chapter 5. Facial Injectable Market: Segment Analysis, By Application, 2016 - 2028 (USD Million)5.1. Definitions & Scope5.2. Application market share analysis, 2020 & 20285.3. Global Facial Injectable Market, By Application, 2016 - 20285.4. Market Size & Forecasts and Trend Analysis, 2016 - 2028 for the following5.4.1. Aesthetics5.4.2. TherapeuticsChapter 6. Facial Injectable Market: Regional Market Analysis, By Region, 2016 - 2028 (USD Million)6.1. Definitions & Scope6.2. Regional market share analysis, 2020 & 20286.3. Regional Market Dashboard6.4. Market Size, & Forecasts, and Trend Analysis, 2020 to 2028Chapter 7. Facial Injectable Market - Competitive Analysis7.1. Company/Competition Categorization (Key innovators, Market leaders, Emerging players)7.2. Vendor Landscape7.2.1. List of key distributors and channel partners7.3. Key companies profiled ALLERGANIpsenMerz PharmaSuneva Medical, Inc.Medytox Inc.Sinclair PharmaBloomage BioTechnology Corporation LimitedAnika Therapeutics, Inc.Prollenium Medical Technologies Inc.Galderma S.A. For more information about this report visit https://www.researchandmarkets.com/r/zgz3y2 CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager email@example.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
The "Mindfulness Meditation Apps Market Share, Size, Trends, Industry Analysis Report, By Operating System; By Service Type; By Age Group; By Regions; Segment Forecast, 2020-2027" report has been added to ResearchAndMarkets.com's offering.